| Thu, Oct 1, 2009 | | • | Navy to fund Vical's swine flu vaccine
at MarketWatch (Thu, Oct 1)
| | • | U.S. Navy to Fund Vical's H1N1 Pandemic Influenza (Swine Flu) Vaccine
GlobeNewswire (Thu, Oct 1)
| | Mon, Sep 28, 2009 | | • | Vical Licensee Sanofi-aventis Completes Enrollment in Phase 3 Angiogenesis Trial
GlobeNewswire (Mon, Sep 28)
| | Thu, Sep 24, 2009 | | • | Vical up after cancer vaccine study
at MarketWatch (Thu, Sep 24)
| | • | Vical Presents Positive Preclinical Results with Vaxfectin(R)-Formulated, Peptide-based Cancer Vaccine
GlobeNewswire (Thu, Sep 24)
| | Mon, Sep 14, 2009 | | • | Detailed Data From Vical's TransVax(TM) CMV Vaccine Phase 2 Trial Presented in Late-Breaker Session at ICAAC
GlobeNewswire (Mon, Sep 14)
| | Thu, Sep 10, 2009 | | • | Vical Pandemic Influenza Vaccine Demonstrates Cross-reactivity Against California, Texas and Mexico H1N1 Strains
GlobeNewswire (Thu, Sep 10)
| | Tue, Sep 8, 2009 | | • | 5 Stocks Bucking the Downtrend
at Motley Fool (Tue, Sep 8)
| | • | Vical Receives $2.5 Million Payment for Funding of Allovectin-7(r) Phase 3 Trial
GlobeNewswire (Tue, Sep 8)
| | Thu, Sep 3, 2009 | | • | Vical Receives Broad U.S. Patent for Vaxfectin(R)-Formulated DNA Vaccines for Influenza; Coverage Includes All Seasonal and Pandemic Strains
GlobeNewswire (Thu, Sep 3)
| | Wed, Sep 2, 2009 | | • | Vical to Present At Upcoming Investor Conferences
GlobeNewswire (Wed, Sep 2)
| | Fri, Aug 7, 2009 | | • | VICAL INC Files SEC form 10-Q, Quarterly Report
EDGAR Online (Fri, Aug 7)
| | Thu, Aug 6, 2009 | | • | VICAL INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
EDGAR Online (Thu, Aug 6)
| | • | Vical Reports Second Quarter 2009 Financial Results and Updates Progress in Key Programs
GlobeNewswire (Thu, Aug 6)
| | Mon, Aug 3, 2009 | | • | Vical and Teva Establish Sales and Marketing Agreement for Allovectin-7(r) in Israel
GlobeNewswire (Mon, Aug 3)
| | Thu, Jul 30, 2009 | | • | Vical Announces News Release and Conference Call Schedule For Second Quarter 2009 Financial Results
GlobeNewswire (Thu, Jul 30)
| | Tue, Jul 28, 2009 | | • | VICAL INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits
EDGAR Online (Tue, Jul 28)
| | • | Federated Kaufmann Funds to Invest $10 Million in Vical
GlobeNewswire (Tue, Jul 28)
| | Fri, Jul 24, 2009 | | • | 5 Cold Stocks Heating Up
at Motley Fool (Fri, Jul 24)
| | Wed, Jul 8, 2009 | | • | Vical TransVax(tm) CMV Vaccine Achieves Promising Interim Clinical Results in Phase 2 Trial
GlobeNewswire (Wed, Jul 8)
| | Tue, Jul 7, 2009 | | • | Vical Announces News Release and Conference Call/Webcast Schedule to Present TransVax(tm) CMV Vaccine Phase 2 Interim Efficacy Results
GlobeNewswire (Tue, Jul 7)
| | Tue, Jun 30, 2009 | | • | Vical H1 Influenza Vaccine Delivers Robust Preclinical Results With 100% Response
GlobeNewswire (Tue, Jun 30)
| | Mon, Jun 22, 2009 | | • | Vical Receives Milestone Payment From Merck & Co., Inc.
GlobeNewswire (Mon, Jun 22)
| | Thu, Jun 18, 2009 | | • | Vical Advances RapidResponse(tm) DNA Vaccine Platform Under $6 Million Grant From NIH
GlobeNewswire (Thu, Jun 18)
| | Wed, Jun 3, 2009 | | • | Vical Announces Issuance of U.S. Patent for Universal Influenza Vaccine Approach
GlobeNewswire (Wed, Jun 3)
|
Add VICL News to My Yahoo!:
 
| |
|
0.11% Nasdaq 
0.01%
Headlines
